Yes - they sure are being quiet over there. I hope that's a good thing! They're a bargain if management can get this to market. If it dies in pipeline because they couldn't raise enough money - its just a loss. A huge loss - because it is cutting edge science. I believe they'll get it there. They have shown resourcefulness and tenacity. I will hold my shares - but I wouldn't put any money here that can't be lost. It won't be the science that kills them, it'll be lack of ability to fund their trials to commercialization.